Immunization with the XCL1/glypican-3 fusion gene generates potent antitumor cellular immunity and enhances the anti-PD1 effect to suspend hepatocellular carcinoma development
EUROPEAN JOURNAL OF IMMUNOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要